Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Our current metabolic peptide research selection includes semaglutide (single GLP-1 agonist), tirzepatide (dual GLP-1/GIP agonist), and retatrutide (triple GLP-1/GIP/glucagon agonist)
Peptide therapy is not about chasing a quick fix
Designed solely for parenteral use (drug administration by intravenous, intramuscular, or subcutaneous injection) following the addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injecting
The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage
Avoid any product in clear glass or plastic without UV protection, or any product combining GHK-Cu with high-concentration vitamin C in the same formula
GHK-Cu delivers copper by design
US$ 27.55
US$ 29.07
US$ 24.44
US$ 20.87
US$ 28.00
